Linagliptin And Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 72205-408

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Linagliptin And Metformin Hydrochloride (NDC 72205-408). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lina-met-tabs--figure-1 (Lina Met Tabs Figure 1)

A line graph depicting the adjusted A1C (%) change from baseline over a 24-week period for different treatment groups including placebo, Metformin 500 mg bid, Metformin 1000 mg bid, Linagliptin 5 mg, Linagliptin 2.5 mg + Metformin 500 mg bid, and Linagliptin 2.5 mg + Metformin 1000 mg bid. The x-axis represents weeks, and the y-axis represents the A1C change from baseline.*

FDA Label Image

Lina-met-tabs--figure-3 (Lina Met Tabs Figure 3)

A line graph comparing the percentage of patients with fracture over time between Linagliptin and Glimepiride groups up to 7 years. The x-axis shows years, and the y-axis shows the percentage of patients with fractures. Patient counts at risk are listed below the graph for both groups across different time points.*

FDA Label Image

Lina-met-tabs-2-5mg-1000mg-180s-count (Lina Met Tabs 2 5mg 1000mg 180s Count)

Label for Linagliptin and Metformin Hydrochloride Tablets 2.5 mg/1,000 mg, film-coated oral tablets. The label indicates prescription use and a quantity of 180 tablets. It includes manufacturer information for MSN Laboratories Private Limited in India and distributor information for Novadoz Pharmaceuticals LLC in New Jersey. Storage instructions and a pharmacist dispensing note are also present.*

FDA Label Image

Lina-met-tabs-2-5mg-1000mg-60s-count (Lina Met Tabs 2 5mg 1000mg 60s Count)

Label for Linagliptin and Metformin Hydrochloride Tablets, film coated, with strength 2.5 mg linagliptin and 1,000 mg metformin hydrochloride per tablet. The package contains 60 tablets. Manufactured by MSN Laboratories Private Limited and distributed by Novadoz Pharmaceuticals LLC. Storage instructions and a pharmacist's guide note are also included on the label.*

FDA Label Image

Lina-met-tabs-2-5mg-500mg-180s-count (Lina Met Tabs 2 5mg 500mg 180s Count)

Label for Linagliptin and Metformin Hydrochloride Tablets 2.5 mg/500 mg, film-coated oral tablets. The label shows a quantity of 180 tablets. Manufactured by MSN Laboratories Private Limited, India, and distributed by Novadoz Pharmaceuticals LLC, New Jersey. The label includes storage instructions, NDC 72205-407-02, and barcode.*

FDA Label Image

Lina-met-tabs-2-5mg-500mg-60s-count (Lina Met Tabs 2 5mg 500mg 60s Count)

Label for Linagliptin and Metformin Hydrochloride Tablets 2.5 mg/500 mg film-coated tablets, prescription drug by Novadoz Pharmaceuticals LLC. Package contains 60 tablets. Manufacturer is MSN Laboratories Private Limited, India. Storage instructions and pharmacist medication guide note are included. Barcodes and contact information for Novadoz are visible.*

FDA Label Image

Lina-met-tabs-2-5mg-850mg-180s-count (Lina Met Tabs 2 5mg 850mg 180s Count)

Label for Linagliptin and Metformin Hydrochloride Tablets, 2.5 mg/850 mg strength. This prescription oral film-coated tablet package contains 180 tablets. Manufactured by MSN Laboratories Private Limited, India, and distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ. Storage instructions and pharmacist dispensing guidance are included on the label.*

FDA Label Image

Lina-met-tabs-2-5mg-850mg-60s-count (Lina Met Tabs 2 5mg 850mg 60s Count)

Packaging label for Linagliptin and Metformin Hydrochloride Tablets, 2.5 mg/850 mg strength. The label indicates the product is a prescription drug in film-coated tablet form, with a package containing 60 tablets. Manufactured by MSN Laboratories Private Limited, India, and distributed by Novadoz Pharmaceuticals LLC. Storage instructions and pharmacist dispensing guidance are also included.*

FDA Label Image

Lina-met-tabs-figure-2 (Lina Met Tabs Figure 2)

A line graph comparing the percentage of patients with events over a 3.5-year period for placebo and linagliptin groups. The graph includes patient counts at risk over time, showing similar event trends between the two groups.*

FDA Label Image

Lina-met-tabs-structure1 (Lina Met Tabs Structure1)

Chemical structure diagram of linagliptin, one of the active ingredients in Linagliptin and metformin hydrochloride tablets. The diagram shows the molecular arrangement including nitrogen, oxygen, and carbon atoms in the linagliptin molecule.*

FDA Label Image

Lina-met-tabs-structure2 (Lina Met Tabs Structure2)

Chemical structure of linagliptin hydrochloride showing molecular composition including nitrogen and methyl groups, alongside the hydrogen chloride component as indicated by the HCl notation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.